[Clinical evaluation of a preparation with antistenocardiac action, 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
D001713:Biphenyl Compounds; D003327:Coronary Disease; D006801:Humans; D011299:Prenylamine; D011437:Propylamines
D001713:Biphenyl Compounds; D011299:Prenylamine; D011437:Propylamines; C010574:biphenyl
CORONARY DISEASE; SEGONTIN